We would like to notify you the revised dates for BSVI Decommissioning.
The BSVI decommissioning dates have been moved to align with the Mira release dates. The new BSVI decommissioning dates are: BSVI UAT access removal: Thursday, 21 March 2024 BSVI Production access removal: Wednesday, 10 April 2024
Please ensure you complete any outstanding actions in advance of these dates.
We will be holding several drop-in sessions for users of the Cancer DSS. These session are an opportunity for you to raise any questions either around the functionality or generally.
- Friday, 15 March 12.00-13.00 - Friday, 22 March 12.00-13.00
Invites to these sessions will be sent out separately.
Posted Mar 15, 2024 - 09:58 GMT
Update
Dear all,
Further to our previous communication to you regarding decommissioning of BSVI, we would like to highlight below information.
Please note that due to the Mira code release, from Thursday, 11 April 2024 onwards any new cases will not be visible in BSVI and can only be reviewed in the new Cancer DSS.
Soon after on Friday, 12 April 2024, your access to BSVI in all environments will be revoked, please ensure you complete any actions in advance of this date.
Posted Mar 01, 2024 - 13:41 GMT
Scheduled
Dear all,
As previously communicated, Genomics England’s Cancer DSS has replaced Illumina’s BaseSpace Variant Interpreter (BSVI) as the provided cancer decision support system.
We will now be progressing with the decommission of BSVI.
As your access to BSVI in all environments will be revoked on Friday, 12 April 2024, please ensure you complete any actions in advance of this date.
There are ~15 older cases open in BSVI that are not in the new Cancer DSS currently. We are working towards migrating these cases but request that you also work towards closing these cases in BSVI or requesting a migration before Friday, 5 April 2024.
Posted Feb 22, 2024 - 15:59 GMT
This scheduled maintenance affected: NGIS_Production_Environment (General_Service_Updates_NGIS_Production, NGIS_PROD_BSVI).